20112020

Forskningsoutput per år

Om du gjort några ändringar i Pure kommer de visas här snart.

Publikationer

Filter
Artikel
2020

Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients

Kasanen, H., Hernberg, M., Mäkelä, S., Brück, O., Juteau, S., Kohtamäki, L., Ilander, M., Mustjoki, S. & Kreutzman, A., 8 feb 2020, I : Cancer Immunology, Immunotherapy. 14 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival

Brück, O., Dufva, O., Hohtari, H., Blom, S., Turkki, R., Ilander, M., Kovanen, P., Pallaud, C., Ramos, P. M., Lähteenmäki, H., Välimäki, K., El Missiry, M., Ribeiro, A., Kallioniemi, O., Porkka, K., Pellinen, T. & Mustjoki, S., 28 jan 2020, I : Blood advances. 4, 2, s. 274-286 13 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy

Soderlund, S., Persson, I., Ilanderd, M., Guilhot, J., Hjorth-Hansen, H., Koskenvesa, P., Richter, J., Saussele, S., Mustjoki, S. & Olsson-Strömberg, U., mar 2020, I : Leukemia Research. 90, 7 s., 106310.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

2019

Novel TMEM173 Mutation and the Role of Disease Modifying Alleles

Keskitalo, S., Haapaniemi, E., Einarsdottir, E., Rajamäki, K., Heikkilä, H., Ilander, M., Pöyhönen, M., Morgunova, E., Hokynar, K., Lagström, S., Kivirikko, S., Mustjoki, S., Eklund, K., Saarela, J., Kere, J., Seppänen, M. R. J., Ranki, A., Hannula-Jouppi, K. & Varjosalo, M., 5 dec 2019, I : Frontiers in Immunology. 10, 17 s., 2770.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy

Haikala, H. M., Anttila, J. M., Marques, E., Raatikainen, T., Ilander, M., Hakanen, H., Ala-Hongisto, H., Savelius, M., Balboa, D., Von Eyss, B., Eskelinen, V., Munne, P., Nieminen, A. I., Otonkoski, T., Schüler, J., Laajala, T. D., Aittokallio, T., Sihto, H., Mattson, J., Heikkilä, P. & 7 andra, Leidenius, M., Joensuu, H., Mustjoki, S., Kovanen, P., Eilers, M., Leverson, J. D. & Klefström, J., 6 feb 2019, I : Nature Communications. 10, 17 s., 620.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil
2018

Divergent roles for antigenic drive in the aetiology of primary versus dasatinib-associated CD8(+) TCR-Vβ(+) expansions

Lissina, A., McLaren, J. E., Ilander, M., Andersson, E. I., Lewis, C. S., Clement, M., Herman, A., Ladell, K., Llewellyn-Lacey, S., Miners, K. L., Gostick, E., Melenhorst, J. J., Barrett, A. J., Price, D. A., Mustjoki, S. & Wooldridge, L., 7 feb 2018, I : Scientific Reports. 8, 12 s., 2534.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Immune cell phenotype and functional defects in Netherton syndrome

Eränkö, E., Ilander, M., Tuomiranta, M., Mäkitie, A., Lassila, T., Kreutzman, A., Klemetti, P., Mustjoki, S., Hannula-Jouppi, K. & Ranki, A., 26 nov 2018, I : Orphanet journal of rare diseases. 13, 10 s., 213.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil
2017

Combined immunodeficiency and hypoglycemia associated with mutations in hypoxia upregulated 1

Haapaniemi, E. M., Fogarty, C., Keskitalo, S., Katayama, S., Vihinen, H., Ilander, M., Mustjoki, S., Krjutskov, K., Lehto, M., Hautala, T., Eriksson-Rosenberg, O., Jokitalo, E., Velagapudi, V., Varjosalo, M., Seppanen, M. & Kere, J., apr 2017, I : Journal of Allergy and Clinical Immunology. 139, 4, s. 1391-+ 14 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskaplig

Öppen tillgång
Fil

Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models

Hekim, C., Ilander, M., Yan, J., Michaud, E., Smykla, R., Vaha-Koskela, M., Savola, P., Tahtinen, S., Saikko, L., Hemminki, A., Kovanen, P. E., Porkka, K., Lee, F. Y. F. & Mustjoki, S., feb 2017, I : Cancer immunology research. 5, 2, s. 157-169 13 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång

Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner

Kreutzman, A., Colom-Fernandez, B., Marcos Jimenez, A., Ilander, M., Cuesta-Mateos, C., Perez-Garcia, Y., Delgado Arevalo, C., Bruck, O., Hakanen, H., Saarela, J., Ortega-Carrion, A., de Rosendo, A., Juanes-Garcia, A., Luis Steegmann, J., Mustjoki, S., Vicente-Manzanares, M. & Munoz-Calleja, C., 1 nov 2017, I : Clinical Cancer Research. 23, 21, s. 6697-6707 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

Ilander, M., Olsson-Stromberg, U., Schlums, H., Guilhot, J., Bruck, O., Lahteenmaki, H., Kasanen, T., Koskenvesa, P., Soderlund, S., Hoglund, M., Markevarn, B., Sjalander, A., Lotfi, K., Dreimane, A., Lubking, A., Holm, E., Bjoreman, M., Lehmann, S., Stenke, L., Ohm, L. & 11 andra, Gedde-Dahl, T., Majeed, W., Ehrencrona, H., Koskela, S., Saussele, S., Mahon, F-X., Porkka, K., Hjorth-Hansen, H., Bryceson, Y. T., Richter, J. & Mustjoki, S., maj 2017, I : Leukemia. 31, 5, s. 1108-1116 9 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
2016

Intrafamily and Interfamilial Phenotype Variation and Immature Immunity in Patients With Netherton Syndrome and Finnish SPINK5 Founder Mutation

Hannula-Jouppi, K., Laasanen, S-L., Ilander, M., Furio, L., Tuomiranta, M., Marttila, R., Jeskanen, L., Häyry, V., Kanerva, M., Kivirikko, S., Tuomi, M-L., Heikkila, H., Mustjoki, S., Hovnanian, A. & Ranki, A., apr 2016, I : Jama dermatology. 152, 4, s. 435-442 8 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
2014

Dasatinib promotes Th1-type responses in granzyme B expressing T-cells

Kreutzman, A., Ilander, M., Porkka, K., Vakkila, J. & Mustjoki, S., 1 maj 2014, I : OncoImmunology. 3, e28925.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-alpha Monotherapy

Ilander, M., Kreutzman, A., Rohon, P., Melo, T., Faber, E., Porkka, K., Vakkila, J. & Mustjoki, S., 31 jan 2014, I : PLoS One. 9, 1, 11 s., 87794.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Immunology and Immunotherapy of Chronic Myeloid Leukemia

Ilander, M., Hekim, C. & Mustjoki, S., mar 2014, I : Current hematologic malignancy reports. 9, 1, s. 17-23 7 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

2011

Intracerebral Borna disease virus infection of bank voles leading to peripheral spread and reverse transcription of viral RNA

Kinnunen, P. M., Inkeroinen, H., Ilander, M., Kallio, E. R., Heikkilä, H. P., Koskela, E., Mappes, T., Palva, A., Vaheri, A., Kipar, A. & Vapalahti, O., 2011, I : PLoS One. 6, 8, s. e23622 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil